Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19.

Alex C SpyropoulosStuart L CohenEugenia GianosNina KohnDimitrios GiannisSaurav ChatterjeeMark GoldinMarty LesserKevin CoppaJamie S HirschThomas McGinnMatthew A Barishnull null

Published in: Research and practice in thrombosis and haemostasis (2021)

The IMPROVE-DD VTE RAM demonstrated very good discrimination to identify hospitalized patients with COVID-19 as low, moderate, and high VTE risk in this large external validation study with potential to individualize thromboprophylactic strategies.

Keyphrases

venous thromboembolism
risk assessment
direct oral anticoagulants
human health
heavy metals
high intensity